Treatment-Resistant Depression: Reassessment and Next-Step Care

Evidence checked 2026-09-24 · 6.85 min read

Updated 24 September 2026. Educational information, not confirmation that an individual meets a treatment-resistance definition or qualifies for a specialist intervention.

A label should organize care, not close it down

Treatment resistance can sound like a permanent verdict. Clinically, it is more useful as a description of what has happened so far and a reason to examine the next steps. It should not imply that the person is resisting help or that every possible approach has failed.

The NIMH brain-stimulation guide discusses options used when other treatments have not been sufficient. Their availability does not guarantee response, but it shows why an unsuccessful first or second approach should lead to informed reassessment rather than abandonment of care.

Check what counts as an adequate previous trial

A medicine taken briefly and stopped because of an adverse effect is different from one taken consistently for an appropriate period without meaningful benefit. Similarly, attending supportive appointments is not necessarily the same as completing a defined psychological treatment.

Ask the clinician how adequacy is being judged in your case. The answer should account for the medicine, dose prescribed, duration, tolerability and actual use. Do not independently extend or increase a prescription to make the history appear to meet a definition.

Prepare a treatment history that explains outcomes

List the names or approaches tried, approximate dates, what improved, adverse effects and why each ended. Include psychological treatment, not only medicines. If records are incomplete, state that rather than inventing details.

A short table or written summary can be useful for an appointment, but it need not be perfect before you seek help. Ask previous services for relevant records where practical. The goal is to avoid repeating an unsuitable intervention or overlooking an earlier treatment that helped.

Separate no response from partial response

A treatment may improve sleep or anxiety while leaving low mood or loss of interest largely unchanged. Another may reduce symptoms but not restore daily functioning. These are different outcomes from no change at all.

Describe the remaining difficulty in concrete terms. For example, you may be attending work but unable to maintain meals or relationships afterward. A review should consider the balance of benefit and burden rather than declare success from one improved score or failure from one persistent symptom.

Revisit the diagnosis and episode history

A history of mania or hypomania can change the interpretation of depressive episodes and medication choices. Anxiety, OCD, trauma-related symptoms or other conditions may also need specific treatment. Reassessment should clarify the pattern rather than add labels without a purpose.

Our bipolar comparison guide explains why lifetime changes in energy, sleep and behavior matter. Share those experiences even when they felt productive or occurred years ago. A revised understanding can lead to a more appropriate plan without blaming the person for earlier uncertainty.

Physical health and sleep deserve another look when indicated

Persistent pain, thyroid disease, anemia, sleep disorders, medication effects or another illness may contribute to the presentation. A clinician should select examination and tests according to the history, not order every available panel or assume that all persistent symptoms are psychiatric.

Our medical-contributors guide and chronic-illness guide discuss coordinated assessment. A normal initial result does not erase the symptom, while a physical diagnosis does not automatically explain away a coexisting depressive disorder.

Ask whether treatment was practically accessible

Cost, transport, unstable housing, fatigue or unclear instructions can interfere with care. A prescription or referral recorded in a chart does not prove the intervention was actually received as intended.

The NICE further-line treatment recommendations include reviewing personal, social, physical and other mental-health factors when response is limited. Name the barrier specifically so the next plan can address it rather than simply repeat the same inaccessible arrangement.

Psychological treatment may need a different approach or adaptation

Ask which model was used, whether sessions followed a coherent plan and whether the goals matched your difficulties. You may need a different therapy, more focused work or adjustments for disability, language or cognitive symptoms.

A poor therapeutic fit is not proof that all therapy is ineffective. Our therapy-review guide explains how to discuss the relationship, treatment method and practical barriers. A useful review should identify what would change, not simply advise trying harder at an unchanged approach.

Medication strategies need specialist reasoning when complexity increases

A prescriber may consider changing a medicine, combining approaches or adding another treatment in selected circumstances. The benefits, interactions and monitoring requirements vary. More medication is not automatically the appropriate response to every incomplete improvement.

Ask what the proposed change targets and how you will know whether it is worthwhile. Request written instructions, particularly during switching. Do not combine medicines from old prescriptions or copy a regimen from another person whose history may be very different.

Side effects can obscure the treatment picture

Sedation, restlessness, sexual difficulties or emotional blunting may affect functioning even when some depressive symptoms improve. Explain when the problem began and how it changes with treatment. A clinician should consider both illness and medication effects.

Our side-effects guide describes a concise way to prepare for review. Do not assume that persistent impairment means the dose must always increase, or that stopping abruptly is the only way to clarify what is happening.

TMS may be one specialist option

Transcranial magnetic stimulation is delivered through a defined protocol and series of visits. Eligibility, safety precautions, treatment burden and expected benefit need discussion with the treating team. Different protocols and devices should not be treated as identical.

Our TMS guide explains assessment and follow-up questions. Ask what happens after the initial course, how response is measured and which alternatives remain if it does not help. A device’s availability at a clinic does not establish that it is the right next step for you.

ECT may be considered in severe or urgent circumstances

Electroconvulsive therapy can be an option when depression is severe, a rapid response is needed or other care has not helped sufficiently. The decision should include the risks of treatment and of remaining severely unwell, with appropriate consent procedures.

Memory effects deserve an explicit, individualized discussion. Our ECT guide covers the procedure, uncertainties and continuation planning. Neither a frightening cultural image nor a promise of rapid recovery should replace a balanced conversation with a qualified team.

Ketamine and esketamine require precise distinctions

Regulatory indications differ by product, route and country. Approved esketamine treatment should not be conflated with compounded or off-label ketamine. Supervision, physical monitoring and the plan between appointments are central parts of care.

Our ketamine and esketamine guide describes the current distinctions. Ask which indication and evidence apply to the proposed treatment, and do not interpret rapid symptom change as proof that an ongoing safety risk no longer requires assessment.

Be cautious with tests claiming to identify the one correct treatment

A commercial report may promise to explain why every previous treatment failed. Ask what the test has been validated to do and whether evidence shows that using it improves meaningful outcomes in people like you.

Distinguish information that may assist a prescriber from a claim that a test diagnoses depression or guarantees the right medicine. Cost and technical language do not establish clinical utility. Obtain an independent explanation before using a report to stop established care or purchase a large treatment package.

Choose the level of care through assessment

Specialist outpatient care, intensive programs, residential treatment and hospital admission have different capabilities. The appropriate setting depends on safety, physical needs, functioning and available support, not merely the number of treatments previously tried.

Our inpatient and residential guides explain why accommodation and continuous staff presence are not equivalent to hospital medical capability. Ask how the service handles deterioration and when transfer is required.

Keep goals and continuation visible

Agree on a few meaningful outcomes alongside symptom measures, such as maintaining food intake, participating in a valued activity or feeling less hopeless. A specialist intervention should still connect to ordinary life and the person’s priorities.

Ask who provides follow-up, how prescriptions continue and what happens if symptoms return. Our relapse-prevention guide explains how to plan continuity. A response to an acute course is important, but it does not remove the need for ongoing review.

Frequently asked questions

Does treatment-resistant mean untreatable?

No. It describes previous difficulty responding and should prompt careful reassessment and discussion of further options, not a final verdict.

Does every stopped prescription count as a failed trial?

No. Duration, prescribed dose, actual use, benefit and reasons for stopping all matter. Ask how the clinician interprets each trial.

When should I seek urgent help?

Immediate danger, inability to remain safe, severe psychosis or inability to maintain essential care requires urgent assessment. Use local emergency services and our crisis information rather than waiting for a specialist waiting list.